INTRODUCTION
Over the past five decades, bilateral as well as multilateral donors' approaches to and rationales for funding health related development challenges have varied significantly.
Aid policy during the 1960s focused on macroeconomic growth and public sector capital investment projects, while the 1970s saw a move toward human development initiatives.
Structural adjustment of the 1980s refocused the aid community's attention on economics, this time with an emphasis on privatization and deregulation, only to be replaced in the new millennium by a return to human development with public-private partnerships taking center stage (Périn & Attaran, 2003) . During the 1990s, globalization and the framing of health as a global public good with the potential to impact the national security and economic and political interests of both developed and developing countries (MacKellar, 2005; Archibugi & Bizzarri, 2005; Barrett, 2004) increasingly turned health policy making into a supranational, rather than domestic, process (McMichael & Beaglehole, 2000) .
At the turn of the millennium, awareness that the WHO's ambitious proclamation of 'Health for All by 2000' would not be achieved, coupled with disillusionment of the effectiveness of aid to low-and middle-income countries, prompted a renewed prioritization of health. Official development assistance (ODA) for health given by member countries of the Organization for Economic Cooperation and Development " [a] lmost 90% of world expenditure on health is spent on people bearing less than 10% of the global burden of disease, and 90% of expenditure on medical research is spent on diseases that account for a mere 10 percent of the global burden of disease." Among the first publications to focus on allocations to developing country recipients specifically, MacKellar's (2005) research identified wide gaps between health needs in developing countries and international funding priorities. Shiffman's (2006) work provided further evidence that development assistance for communicable diseases and measures of disease burden are largely unaligned, and Wecker has argued that attention to diarrheal diseases, a major killer of infants, had waned dramatically since the 1980s partly as a result of changing donor priorities, which has allowed them to creep back (quoted in: Mason, 2009 ). At the same time, HIV/AIDS receives a seemingly disproportionate share of funding (Shiffman, 2006) . This is illustrated by AIDS-related mortality figures in Nigeria and Ethiopia-Africa's two most populous nations-in 2007 (237,000) which were "less than half the 540,000 children under 5 [in the same countries] who died of pneumonia and diarrhea" (Dugger, 2009 ). Yet in the same year, the US government's budget for HIV-AIDS related interventions in Nigeria and Ethiopia "was more than the $646 million it is spending on maternal and child health in all the world's countries combined" (ibid.).
An additional complication arises when considering that a recent World Bank report alerts that seven out of ten Bank-financed HIV/AID projects fail to reach their objectives while nine out of ten projects targeting diseases such as malaria, tuberculosis, and leprosy performed satisfactorily or better (IEG, 2009 ).
Clearly then, donor allocations cannot be informed primarily by concerns about existing needs and the desire to improve health status in recipient countries in the most effective manner. Ravishankar et al. (2009 Ravishankar et al. ( : 2121 hypothesize "that country allocation of DAH [development assistance for health] is driven by many considerations, including income, burden of disease, political stability, and historical and political relations between specific donors and recipient countries," thus echoing some of the arguments made by Shiffman (2006) . Yet this does not imply that these factors have equal weight. Indeed, Périn and Attaran (2003) were among the first to argue that aid allocation for health is predominantly a political process determined by donor ideologies. Crane and Dusenberry (2004) emulated this point and emphasized religious underpinnings in the context of family planning and HIV prevention. More recently, Pearlman and Roy (2009: xiv) have reiterated this argument: "The practice of international health is political rather than technical, political rather than bureaucratic, political rather than academic. [...] The choice between interventions is presented as a question of efficacy that can be measured and scientifically evaluated. But the world is not that simple. Choices are often based on ideology, values, and national and organizational interests." An important process in this context is the manipulation of recipient agendas by donors (Walt et al., 1999 ) that may result from one party controlling significant resources while the other party is in serious need (Sewell, 1992) . Reflecting these concerns and based on their finding that "the focus on [...] quick results [by donors] discourages investment in health systems," Sridhar and Rajaie (2008) hypothesize that either different governance structures of the World Bank, national governments, the BMGF and the Global Fund or ostensible comparative advantages between these agencies could explain differences in priority-setting processes.
That decision making structures matter is considered by other authors as well. Within private foundations, "the focus has been on amounts of money raised for high-visibility health problems. A large share of the new donor funding is being provided through channels earmarked for specific diseases or interventions" (Eichler et al., 2009: 42) . The BMGF specifically has been characterized as "emphasiz[ing] breakthrough technologies and cost-effective interventions instead of investing in health-system strengthening and in addressing the underlying causes of disease" (Pearlman & Roy, 2009: 174) . Another foundation has been singled out as pursuing a specific accomplishment in the health field to celebrate an important anniversary: "Rotary International had been looking for a global target to be achieved by the centennial of its foundation in 2005" (De Quadros, 2009: 62) .
Measurability plays an important role in this content because it facilitates resource mobilization as well as the production of easily attributable success stories (Esser, 2009), which causes Eichler et al. (2009: 4) to argue rather bluntly that " [y] ou get what you pay for. And it is easier to pay for what you can easily measure." Finally, where shifts in donor priorities can neither be traced compellingly to shifts in recipient needs nor to provider interests, Shiffman (2006) argues that processes of socialization occurring within the global policy environment could provide an alternative explanation for these shifts." Taking a social constructivist perspective and fielding the example of emerging health alliances during the past ten years, he posits that the decisions of one actor influences the decisions of other donors, ultimately creating a kind of global peer pressure [1] .
Although at least in part still hypothetical, this literature has nonetheless contributed in important ways to a deeper understanding of aid allocation. Yet the question remains to what extent both epidemiological profiles and subjective perceptions in recipient countries matter to different types of funders, if at all. Previous research into this aspect either did not break data down to the country level (Sridhar & Rajaie, 2008) or suffered from methodological problems. The authors of a recent BMGF-funded study that looks at both public and private sources, Ravishankar et al. (2009 Ravishankar et al. ( : 2113 argue that " [t] otal DAH received by low-income and middle-income countries was positively correlated with burden of disease." They also find that " [t] he correlation between health aid and disease burden has risen from 0.6% to 0.8% between 1997 and 2007" (2121) . However, the absence of per capita calculations in their approach constitutes a major limitation; asserting a direct correlation between DAH and DALYs without adjusting for population size is problematic since more populous countries are likely going to have larger disease burdens as well. What follows is that the statistical analysis offered by Ravishankar et al.
is prone to type-I errors, i.e., detecting correlations where, in reality, there are none.
Covering the period from 2005 until 2007, our research design merges datasets on ODA and private funding to nine major areas of health in 27 developing countries with disease burden indicators and data on recipients' priority areas. While methods to measure country-specific disease burdens are widely used, public perceptions of health related challenges in local contexts are a relatively new area of measurement. The Kaiser/Pew Global Health Survey A Global Look at Public Perceptions of Health Problems, Priorities, and Donors (Kaiser Family Foundation, 2007) is the first attempt that allows for a comparative analysis of felt needs with indicators driven by epidemiological rather than opinion data. On this basis, our study develops the first country-specific analysis of public and private donors regarding their responsiveness to two different conceptualizations of recipient needs, and thus offers a fresh look at the responsiveness of development aid more broadly.
METHOD
The Kaiser/Pew Global Health Survey (Kaiser Family Foundation, 2007) Table 1 ). Multi-year grants were included in the analysis in their entirety whereas grants with a regional focus-instead of a country-were excluded. Since ODA data are often also multiyear commitments, multi-year grants were taken as a lump grant and not imputed over the years of the grant in order to capture the signalling function of the commitment at a given point in time.
[add table 1 about here]
All grants (n=2,847) from these top five foundations (n=5) in terms of health commitments for countries included in the study (n=27) were searched for "health", "hunger", "nutrition", then read individually and placed in most relevant Kaiser category. Chronic disease included all DALYs attributed to non-communicable disease.
Immunizations included all DALYs attributable to the childhood cluster diseases (poliomyelitis, measles, pertussis, tetanus, and diphtheria). HIV/AIDS included all DALYs attributable to HIV/AIDS and STDs. Prenatal care included perinatal conditions and maternal conditions. TB/Malaria/Other Infectious diseases included communicable diseases including tuberculosis, malaria, intestinal nematode infections, dengue, hepatitis, meningitis, trachoma, tropical cluster diseases (Chagas disease, lymphatic filariasis, etc.), Japanese encephalitis, leprosy, and respiratory infections. Hunger and Malnutrition comprised all nutritional deficits including Vitamin A, iodine, iron and protein [3] . We collapsed the aid variable into ordinal categories and used Spearman's rho to test the relationship. It is worth noting that because of the reverse demarcation of priorities (1-not 9-being the highest), a negative algebraic sign denotes a positive correlation.
Pearson's r and Spearman's rho were calculated using SPSS 16.0 to analyze correlations between official development assistance and private foundation giving to disease burden (r) and perceived priority (rho). Significance was determined at 95% and 99% confidence intervals (2-tailed). Since the application of Spearman's rho to denote correlation between one ordinal and one interval-ratio set of data may seem problematic, we also converted aid figures into ordinal variables by forming nine categories for ODA amounts and five for private grants and then recalculated the coefficient. This produced virtually identical results, rendering Spearman's rho remarkably robust with only one ordinal variable. In addition, we calculated Pearson's r. While producing lower values of the statistic overall, this computation rendered substantially similar results.
RESULTS
Alignment of donor aid commitments and private funding by the leading five US-based private foundations between 2005 and 2007, public priorities in 27 recipient countries, and country-level disease burden varied greatly across regions. Looking first at total international funding to countries included in the study, India and China received by far the highest total amounts of health aid from both types of funders. Ethiopia was the third most-funded recipient country and first among the nine African countries sampled.
Bangladesh, Kenya, Nigeria, Tanzania, South Africa and Indonesia follow on ranks four to ten. With an increase from over $2.6bn to just shy of $4.7bn, the nine countries in subSaharan Africa also represent the greatest absolute expansion in ODA health funding during the three-year period covered. The greatest relative increase can be registered for the seven countries located in Latin America; however, funding for health purposes also For the five foundations whose grants were analyzed for this study, Nigeria was the most prominent target country, receiving almost $100m over a three-year period. India, Kenya, and Ghana follow on ranks two to four. However, private grants for health projects located in India nonetheless also registered the sharpest absolute decline, from over $44m In absolute terms, this ranking is led by private grants for aid projects in Nigeria where overall private funding jumped from $9.3m in 2005 to just under $60m one year later.
Notably, whereas ODA for health purposes committed to the Asian region between 2005 and 2007 was 40% higher than commitments to Africa, private foundation giving actually showed a reverse pattern, with African countries receiving over 60% more than private grants authorized for projects located in Asia. No grants from foundations covered in the analysis were given to Bolivia, Jordan, Lebanon, or Venezuela (see Table 2 ).
[add table 2 about here]
Regarding the responsiveness of ODA and private funding to national disease burdens, our calculations rendered weak statistical correlations for both sources and all three years reported, none of which were estimated to be significant at the .95 confidence level.
With respect to perceived priorities, we found stronger correlations between ODA and priorities as reported by the Kaiser/Pew Global Health Survey, which were also estimated to be highly significant. Lower indicators of association resulted for private foundation giving and national priorities, and only one of the coefficients-i.e., private grants awarded in 2005-was estimated to be significant at the .95 confidence level.
[add table 3 about here]
The absence of strong correlations between funding streams and disease burden also hints at a similarly weak correlation between priority ranks and disease burden. This was indeed the case. For instance, despite contributing 24 per cent and 12 per cent, respectively, to disease burdens in sub-Saharan Africa and Asia, tuberculosis, malaria and other infectious disease were ranked among the lowest priorities by respondents in the 15 countries included from these two regions. At the other end of extremes, HIV/AIDS was ranked the most important health priority in Asia even though this category contributed to only 3 per cent of the total disease burden. Still, following Clean Water, HIV/AIDS was the next most highly funded health category in Asia overall and the most highly funded one by the five private foundations included in the study (see Table 4 ).
[add table 4 about here]
In order to examine to what extent funding by both types of sources was aligned with disease burden at the country-level, we also created an index of per capita disease burden for each country by dividing the total disease burden for each country by the national population as specified in the Global Burden of Disease Estimates. The total amount of aid given to that country was then divided by this index. We did not find strong evidence of responsiveness at this level either. Among the sub-Saharan countries included in the study, Mali had the highest DALYs-per-capita index (0.68) but received the lowest relative amounts of aid within the sub-Saharan sample from each type of source. Only Venezuela-whose DALYs-per-capita index score was less than 25 per cent of Mali'sreceived less funding per capita and disease burden. The highest private flows, relative to disease burden, went to Kenya, which ranks seventh out of nine countries in terms of per capita disease burden. Kenya also came out second in the ODA ranking, topped only by Ethiopia, which in terms of per capita disease burden ranks fifth within the sub-Saharan sample. The situation was similar for the six Asian and five Middle Eastern countries sampled. China, with a DALYs-per-capita index score of 0.15, received eleven times the amount of grant and loan commitments compared to Pakistan, which bears twice the per capita disease burden. Egypt and Lebanon ranked at the top of their region's per capita disease burden index but together received less funding than Turkey, ranked fourth out of five. Cross-regional comparisons complement this picture further; although Bolivia had a slightly higher per capita burden than Bangladesh, the latter country received more than five times the financial aid on a per capita basis than the Andean state (see Table 5 ).
[add table 5 about here]

DISCUSSION
The results described in the previous section allow us to revisit the alternative drivers of health aid allocation already discussed above, with a view to assessing their relative explanatory power. To begin with, Ravishankar's et al. (2009, op.cit.) hypothesis "that country allocation of DAH is driven by many considerations, including income, burden of disease, political stability, and historical and political relations between specific donors and recipient countries" finds some support. While our study does not test the relevance of donor incomes to this context, we do observe that private foundations seem to prefer politically stable recipient countries (see table 2 
CONCLUDING REMARKS
We would like to see this study being used as a starting point for follow-up investigations of two types of agencies, namely donors and ministries in recipient countries, in order to contribute to a better understanding of decision making dynamics within organizations pivotal for the improvement of health systems and outcomes in developing countries. For instance, while our study considers official aid commitments as well as private funding from the top five US-based private foundations, we do not account for in-country funding sources. Inclusion of such data strikes us as a promising extension of this research in that it would add to the existing literature assessing the degree of 'crowding out' of national funding by international aid (Lu et al., 2010; Sridhar, 2009; Waddington, 2004; cf. Michaud & Murray, 1994) . To illustrate, large amounts of international aid targeted at a specific disease may drive up public prioritization as people become more aware of the issue. This argument has been particularly salient in the context of funding for HIV/AIDS and its critique (Shiffman, 2008) . At the same time, the only way to test Sridhar and Rajaie's (2008) hypothesis that either the governance structures of donor agencies or their internal perception of comparative advantages might explain differences in prioritysetting would be to actually engage with these organizations in depth and for a substantial amount of time. Moving beyond generalized statements or even conspiracy theories, this approach would focus on uncovering the actual political economies at different levels of policy making through embedded observation (cf. Esser, 2009; Sridhar and Rajaie, 2008) .
It then seems to us that such inquiries into formal as well as informal processes of prioritization require a research design which is quite different from the currently dominant macro-level large-n studies of development assistance for health, and that the emerging literature on political ethnographies (cf. Schatz, 2009 ) is likely to lead the way.
NOTES
[1] Donor partnerships such as the GFATM as well as World Bank-led investment alliances command considerable amounts of money and can provide an important opportunity for donor coordination. At the same time, such alliances have raised concerns over 'reverticalizing' health systems and further complicating the administrative requirements of international health assistance (Buse & Harmer, 2007: 263) [2] Although Eastern and Central European countries were included in the Kaiser/Pew Survey, no official development assistance for health was reported for this region and it was therefore omitted from the analysis.
[3] One might argue that international aid in absolute terms is a limited variable since some interventions may cost more than others but also lead to greater gains in DALYs.
To this effect, a comparison of the cost-effectiveness of interventions would be necessary as this would enable comparisons based on the cost per DALY averted. (2002) . Percent Disease Burden was calculated as a percentage of total DALYs; percentage totals will not add to 100% due to the exclusion of DALYs due to injuries. Perceived Priorities represent the perceived priority of people surveyed within each country, are ranked (1-9, 1 the highest priority), and were obtained from the Kaiser/Pew Global Health Survey (2007). Attriubtable DALYs were not assigned to Access to Care or Build/Improve Facilities. Countries in Eastern Europe, although included in the Kaiser/Pew Global Health Survey, did not have sufficient ODA to include in the analysis. 
